A truncated lipoglycan from mycobacteria with altered immunological properties

Area of Science:

• Microbiology
• Immunology
• Biochemistry

Background:

• Cell-wall integrity in Mycobacterium tuberculosis is vital and targeted by drugs like ethambutol.
• Lipoarabinomannan (LAM) is essential for cell-wall integrity and possesses immunomodulatory functions.

Purpose of the Study:

• To characterize a unique LAM molecule from a mutant Mycobacterium smegmatis lacking arabinofuranosyltransferase AftC (AftC-LAM).
• To elucidate the role of arabinofuranosyltransferases in LAM biosynthesis and ethambutol's mechanism of action.
• To investigate the immunomodulatory activity of AftC-LAM.

Main Methods:

• Isolation and structural characterization of AftC-LAM from Mycobacterium smegmatis.
• Assessment of ethambutol's inhibition of AftC-LAM arabinan core biosynthesis.
• Evaluation of AftC-LAM's ability to activate Toll-like receptor 2 (TLR2) and induce proinflammatory responses.

Main Results:

• AftC-LAM exhibits a truncated arabinan domain, confirming AftC's role in its biosynthesis.
• Ethambutol inhibits the biosynthesis of the AftC-LAM arabinan core, implicating EmbC in early LAM-arabinan synthesis.
• AftC-LAM demonstrates enhanced proinflammatory activity via TLR2 activation.

Conclusions:

• This study clarifies ethambutol's mechanism of action and the function of specific arabinofuranosyltransferases in LAM biosynthesis.
• The findings highlight the role of LAM structure in modulating immune responses.
• Chemically defined LAM variants are valuable tools for studying structure-function relationships in TLR2 activation.